TORONTO, ONTARIO: Company expects to announce primary clinical outcome results by end of September Final module of PMA submission anticipated in Q4 2016
...
TORONTO, ONTARIO: Company remains on track and anticipates final submission in Q4 2016 FDA accepts Spectral's 510(k) filing for its standalone pump for review
...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.